Fresh from the biotech pipeline: record-breaking FDA approvals

12Citations
Citations of this article
52Readers
Mendeley users who have this article in their library.
Get full text

Abstract

New drug approvals reached an all-time high in 2023, with five gene therapies, the first CRISPR–Cas9-edited therapy and a disease-modifying Alzheimer’s drug.

Cite

CITATION STYLE

APA

Senior, M. (2024, March 1). Fresh from the biotech pipeline: record-breaking FDA approvals. Nature Biotechnology. Nature Research. https://doi.org/10.1038/s41587-024-02166-7

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free